When discussing advancements in the healthcare industry, the name Scott Rocklage is bound to make its way into the conversation. Dr. Rocklage is a decorated professional with multiple years of experience in the field of medicine, however his resume extends beyond just these accomplishes.

Throughout the years, Dr. Rocklage has helped to grow other business and generate new products for the healthcare industry. His accomplishments have had a global effect, yet Dr. Rocklage is able to stay grounded in his own principles.

The foundation of knowledge that Dr. Rocklage possesses begins with his comprehensive education in the field of chemistry. Rocklage was a graduate of the University of California and Berkeley and he earned his Bachelor of Science in Chemistry while studying there. Learn more about Scott Rocklage: http://www.rennovia.com/team/scott-m-rocklage/ and http://www.thestylemaponline.com/the-amazing-career-of-scott-rocklage-of-5am-ventures/

In order to further his own education, Dr. Rocklage continued studying chemistry at the Massachusetts Institute of Technology (MIT) and personally worked with Nobel Prize winner Richard R. Schrock.

His time at MIT would earn Dr. Rocklage a Ph.D. in Chemistry and lead to the start of his exceptional career in healthcare and healthcare management.

Rocklage has served as CEO and chairman for Cubist Pharmaceuticals, in addition to leadership positions at other corporations such as Relyspa and Kinestral. Rocklage’s strong sense for entrepreneurship has helped him to grow these companies and create more innovative visions for the future of medicine.

Dr. Rockalage’s success as a businessman is rivalled only by his accolades from excelling in science. He currently has been a part of over 30 patents that were registered in the United States.

In addition, Rocklage has over 100 publications to his name that are peer-reviewed. Dr. Scott Rocklage is currently based in the Boston offices of 5AM Ventures.

Dr. Scott Rocklage joined 5AM Ventures as one of its partners over a decade ago in 2003.

Shortly thereafter during the year 2004, he became an official managing partner of the firm and uses his managerial skills in the healthcare industry to improve business models and increase productivity for startups and large corporations alike.

His guidance has led to three new medications being available to the public, all with the backing of FDA approval.